Tumor Ablation Market in Asia Pacific is expected to register a CAGR of 13.1% during the forecast period (2019-2025) - KBV Research

According to a new report Asia Pacific Tumor Ablation Market, published by KBV Research, the Asia Pacific Tumor Ablation Market would witness market growth of 13.1% CAGR during the forecast period (2019-2025).

The China market dominated the Asia Pacific Lung Cancer Market by Country 2018, and would continue to be a dominant market till 2025. The Japan market is anticipated to grow at a CAGR of 13.7% during (2019 - 2025). Additionally, The India market would witness a CAGR of 15.5% during (2019 - 2025).

The Surgical Ablation market dominated the South Korea Tumor Ablation Market by Treatment 2018, growing at a CAGR of 14.7 % during the forecast period. The Laparoscopic Ablation market is expected to witness a CAGR of 14.9% during (2019 - 2025). Additionally, The Percutaneous Ablation market is experiencing a growth rate CAGR of 16% during (2019 - 2025).

The Radiofrequency Ablation market dominated the Singapore Tumor Ablation Market by Technology 2018, thereby, achieving a market value of $6.3 million by 2025. The Microwave Ablation market is experiencing a growth rate of 14.5% during (2019 - 2025). Additionally, The Cryoablation market is expected to witness highest CAGR of 16.2% during (2019 - 2025).

Structural Insights: https://www.kbvresearch.com/asia-pacific-tumor-ablation-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Medtronic PLC, Johnson and Johnson (Ethicon, Inc.), Boston Scientific Corporation, Misonix, Inc., EDAP TMS S.A., Theraclion SA, AngioDynamics, Inc., Mermaid Medical A/S, HealthTronics, Inc. (Altaris Capital Partners, LLC), and SonaCare Medical, LLC.

Asia Pacific Tumor Ablation Market Segmentation

By Treatment

• Surgical Ablation
• Laparoscopic Ablation and
• Percutaneous Ablation

By Technology

• Radiofrequency Ablation
• Microwave Ablation
• Cryoablation
• Irreversible Electroporation and
• Other Technology

By Application

• Liver Cancer
• Breast Cancer
• Lung Cancer
• Kidney Cancer
• Prostate Cancer and
• Other Cancer

By Country

• China Tumor Ablation Market
• Japan Tumor Ablation Market
• India Tumor Ablation Market
• South Korea Tumor Ablation Market
• Singapore Tumor Ablation Market
• Australia Tumor Ablation Market
• Rest of Asia Pacific Tumor Ablation Market

Companies Profiled

• Medtronic PLC
• Johnson and Johnson (Ethicon, Inc.)
• Boston Scientific Corporation
• Misonix, Inc.
• EDAP TMS S.A.
• Theraclion SA
• AngioDynamics, Inc.
• Mermaid Medical A/S
• HealthTronics, Inc. (Altaris Capital Partners, LLC)
• SonaCare Medical, LLC

Unique Offerings from KBV Research

• Exhaustive coverage
• The Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free

Tumor Ablation Market Related Reports:

Global Market

North America Market

Europe Market

LAMEA Market